ACYCLOVIR

NDC 59651-493 · Aurobindo Pharma Limited

Generic nameACYCLOVIR

Dosage formSUSPENSION

RouteORAL

Active ingredient(s)ACYCLOVIR

Strength200 mg/5mL

Pharmacologic classDNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]

Marketing categoryANDA

Packages

59651-493-47 — 473 mL in 1 BOTTLE (59651-493-47)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51655-300 — Acyclovir, 51655-679 — Acyclovir, 51655-965 — acyclovir, 51672-1360 — Acyclovir, 51672-1361 — Acyclovir, 54348-624 — ACYCLOVIR, 54348-627 — Acyclovir, 55154-0199 — acyclovir, 55154-4332 — Acyclovir, 55154-7629 — ACYCLOVIR, 59651-965 — ACYCLOVIR, 59651-966 — ACYCLOVIR, 60505-0042 — ACYCLOVIR, 60505-5306 — acyclovir, 60505-5307 — acyclovir, 60687-856 — ACYCLOVIR, 60687-867 — ACYCLOVIR, 60760-778 — Acyclovir, 61442-112 — Acyclovir, 61442-113 — Acyclovir, +172 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels